Elevation Pharma Raises $30 Million
Elevation Pharmaceuticals Inc., a San Diego-based developer of aerosol therapies for patients with respiratory diseases, has raised $30 million in Series A funding. Backers include Canaan Partners, TPG Growth, Care Capital and Mesa Verde Venture Partners.
21 January 2010•3 mins read
